Shanghai Hile Bio-Technology shareholders appoint 2025 auditor

Shanghai Hile Bio-Technology held its second extraordinary general meeting of shareholders on November 14, 2025, at its Shanghai office. The meeting saw 252 shareholders and proxies in attendance, representing 259,310,209 shares, or 39.5493% of the total voting shares. The meeting, convened by the board and chaired by Mr. Zhang Haiming, primarily addressed the appointment of the company's accounting firm for the 2025 financial year.

The sole agenda item, regarding the appointment of the 2025 accounting firm, was approved by shareholders. A-share holders voted 258,572,309 in favor (99.7154%), with 646,800 votes against (0.2494%), and 91,100 abstentions (0.0352%). For shareholders holding less than 5%, the vote was 8,652,621 in favor (92.1420%), 646,800 against (6.8877%), and 91,100 abstentions (0.9703%).

Shanghai Tongli Law Firm, represented by attorneys Zhang Zhixie and Xu Anchang, attested that the meeting's convening and procedures complied with relevant laws and company articles, and the resolutions passed are legal and effective. The board had approved this proposal on October 28, 2025.